Suspension of trading
Quotes Eiger BioPharmaceuticals
Stocks
EIGR
US28249U2042
Biotechnology & Medical Research
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.500 USD | -.--% |
|
-.--% | - |
| 01/10/24 | Eiger BioPharmaceuticals Files for Chapter 11 Bankruptcy as Liquidation Plan Takes Effect | CI |
| 30/09/24 | Eiger BioPharmaceuticals, Inc. Went Out of Business | CI |
Performance
| 3 years | -63.75% | ||
| 5 years | -96.59% | ||
| 10 years | -98.52% |
Volumes
marketsDaily volume
1,592
Estimated daily volume
1,592
Record volume 1
2,936,479
Record volume 2
1,307,405
Record volume 3
975,732
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (USD)
12,586,774
Net sales ()
16
Number of employees
25
Sales / Employee ()
1
Sales / Employee (USD)
1
Free-Float
86.47 %
Free-Float capitalization (USD)
10,883,196
Indicators
Moving average 5 days
8.5
Moving average 100 days
8.438
Price spread / (MMA5)
-.--%
Price spread / (MMA100)
-0.72%
STIM
RSI 9 days
0
RSI 14 days
0
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | -.--% | -63.75% | 12.59M | |
| -4.89% | -7.90% | -4.49% | +9.27% | 48.5B | |
| -0.14% | -1.05% | +376.39% | +583.71% | 38.97B | |
| +0.39% | +4.36% | +9.59% | +61.99% | 35.43B | |
| -1.54% | -4.48% | +24.89% | -13.03% | 33.65B | |
| -0.87% | -1.56% | -1.43% | +29.16% | 26.58B | |
| -1.28% | -5.14% | - | - | 16.82B | |
| -0.67% | -1.50% | +70.98% | +115.31% | 15.18B | |
| +1.32% | +2.29% | +14.62% | +15.52% | 13.89B | |
| +0.40% | -0.41% | +19.80% | -31.98% | 12.76B | |
| Average | -0.73% | -1.09% | +56.71% | +78.47% | 24.18B | |
| Weighted average by Cap. | -1.29% | -1.28% | +76.11% | +121.28% |
Historical Quotes: Eiger BioPharmaceuticals
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Course Extremes
| 3 years | 1.1 |  | 28.5 |
| 5 years | 1.1 | | 300.64 |
| 10 years | 1.1 | | 618.9 |
Monthly variations
Annual variations
| 2024 | +26.21% | ||
| 2023 | -80.97% | ||
| 2022 | -77.26% | ||
| 2021 | -57.77% | ||
| 2020 | -17.52% | ||
| 2019 | +46.65% | ||
| 2018 | -27.17% | ||
| 2017 | +19.74% | ||
| 2016 | -26.69% |
- Stock Market
- Stocks
- EIGR Stock
- Quotes Eiger BioPharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
